Promore Pharma AB (publ) undertook an 18-site clinical trial to further prove the efficacy and safety of ropocamptide (LL-37) for patients with hard to…
With the spread of COVID-19 globally, and the huge range of restrictions and social distancing measures placed on people by governments, health organizations, and…
Our Partners
This website uses cookies to offer you a better browsing experience and analyze site traffic. Read about how we use cookies and how you can control them by clicking “Learn More“. If you continue to use this site, you consent to our use of cookies.